All events

Investor

FT Live Global Pharmaceutical and Biotech Summit

A high level strategic forum analyzing the business, investment, and technological forces shaping the global biopharmaceutical industry.

When
November, Mid November
Where
London, UKView on Google Maps
Format
Hybrid
Organiser
Financial Times
Region
Europe
Scale
About 400 attendees
Founded
2011

The Signal

The Financial Times hosts this annual summit in London to analyze commercial strategies in drug development and biotechnology. It features interviews with pharmaceutical chief executives, biotechnology founders, and major healthcare investors. The program focuses on drug pricing, commercialization strategies, regulatory policies, and the integration of artificial intelligence in drug discovery. It is a key event for corporate strategy officers and life science investment managers.

What to expect

  • Debates on international drug pricing policies and inflation reduction acts
  • Updates on clinical pipeline trends and gene therapy commercialization
  • Analysis of generative artificial intelligence application in drug discovery workflows

Who is in the room

Pharmaceutical executives, biotechnology founders, healthcare investment bankers, and policy analysts attend.

Background

The Financial Times created this event to serve as their flagship executive conference for the life science sector. It has maintained a reputation for high level interviews and rigorous debate on industry economics.

Official event site

Related events

Running this event, or spotted something out of date?

Related reading